2024-09-06 - Analysis Report
## ABT Stock Analysis Report

**Company Overview:** 

Abbott Laboratories (ABT) is a global healthcare company that develops, manufactures, and markets a wide range of products including pharmaceuticals, medical devices, diagnostics, and nutritionals. 

**Performance Analysis:**

**1.  Return Analysis:**

* **Cumulative Return:** ABT has generated a cumulative return of 43.11% compared to S&P 500's (VOO) 84.86%.
* **Performance Gap:** The return gap is -47.7%, indicating ABT underperformed the S&P 500.
* **Relative Gap:** This places ABT at the 14.85 percentile of its historical performance range against the S&P 500.

**2.  Recent Price Movements:**

* **Closing Price:** $114.4
* **5-day Moving Average:** $113.6
* **20-day Moving Average:** $111.45
* **60-day Moving Average:** $107.0

The recent price movement suggests a positive trend as the closing price is above all three moving averages. 

**3.  Technical Indicators:**

* **RSI:** 78.29, indicating the stock is currently in overbought territory.
* **PPO:** 0.08, indicating potential for further growth.
* **Delta_Previous_Relative_Divergence:** -8.38, indicating a recent short-term downward trend.
* **Expected Return:** 27.09%, indicating a potential 5-year projected return based on the current investment amount.

**4.  Recent Earnings & Forecast:**

| Date        | EPS    | Revenue     |
|-------------|--------|-------------|
| 2024-07-31 | 0.74   | 10.38 B$    |
| 2024-05-02 | 0.7    | 9.96 B$    |
| 2023-11-01 | 0.82   | 10.14 B$    |
| 2023-08-03 | 0.79   | 9.98 B$    |
| 2023-07-31 | 0.79   | 9.98 B$    |

ABT's recent earnings have shown a slight decline in the last quarter, with a reported EPS of 0.74, compared to 0.82 in the previous quarter. The company's revenue remains stable, hovering around $10 billion.  

**5.  Overall Analysis:**

ABT's performance has lagged behind the S&P 500 in recent years.  While the current price action shows positive signs, technical indicators suggest the stock is overbought and potentially facing a short-term downtrend. The company's recent earnings show a slight decline, but revenue remains stable. Overall, ABT's performance is mixed, and it's crucial to monitor its future performance closely.

**6.  Conclusion:**

ABT is a large and established company with a diverse portfolio of products. However, its recent performance has lagged behind the broader market. While the current price action shows some positive signs, technical indicators and recent earnings suggest caution. Further monitoring of future performance and market trends is recommended.
